NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
2.160
+0.200 (10.20%)
At close: Mar 6, 2026, 4:00 PM EST
2.450
+0.290 (13.43%)
After-hours: Mar 6, 2026, 7:54 PM EST
NuCana Employees
As of December 31, 2024, NuCana had 22 total employees, including 20 full-time and 2 part-time employees. The number of employees decreased by 6 or -21.43% compared to the previous year.
Employees
22
Change (1Y)
-6
Growth (1Y)
-21.43%
Revenue / Employee
n/a
Profits / Employee
-$1,681,526
Market Cap
8.99M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 57 |
| Bolt Biotherapeutics | 40 |
| KALA BIO | 38 |
| SeaStar Medical Holding | 19 |
| Moleculin Biotech | 17 |
| Cardio Diagnostics Holdings | 15 |
| BioVie | 13 |
| Iterum Therapeutics | 9 |
NCNA News
- 2 months ago - NuCana Appoints Theresa Bruce as Chief Operating Officer - GlobeNewsWire
- 3 months ago - NuCana Presents Latest Data Demonstrating Clinical Activity and Favorable Safety for NUC-7738 in Patients with PD-1-Resistant Melanoma - GlobeNewsWire
- 4 months ago - NuCana Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in China - GlobeNewsWire
- 6 months ago - NuCana Compliant with All Nasdaq Continued Listing Criteria - GlobeNewsWire
- 6 months ago - NuCana to Present Data on NUC-7738's Synergy with PD-1 Inhibitors at the ESMO Congress 2025 - GlobeNewsWire
- 7 months ago - NuCana Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 7 months ago - NuCana Announces ADS Ratio Change - GlobeNewsWire